Triphenylphosphine → (5R)-3-(3-fluoro-4-imidazol-1-yl-phenyl)-5-(isoxazol-3-yloxymethyl)oxazolidin-2-one

HRID 1167462

반응식

HRID 1167462 반응식
[F:1][C:2]1[CH:3]=[C:4]([N:13]2[CH2:17][C@H:16]([CH2:18][OH:19])[O:15][C:14]2=[O:20])[CH:5]=[CH:6][C:7]=1[N:8]1[CH:12]=[CH:11][N:10]=[CH:9]1.O[C:22]1[CH:26]=[CH:25][O:24][N:23]=1.C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.CC(OC(/N=N/C(OC(C)C)=O)=O)C>O1CCCC1>[F:1][C:2]1[CH:3]=[C:4]([N:13]2[CH2:17][C@H:16]([CH2:18][O:19][C:22]3[CH:26]=[CH:25][O:24][N:23]=3)[O:15][C:14]2=[O:20])[CH:5]=[CH:6][C:7]=1[N:8]1[CH:12]=[CH:11][N:10]=[CH:9]1

참가 물질

6

실험 절차

3-(3-Fluoro-4-(imidazol-1-yl)phenyl)-5(R)-hydroxymethyloxazolidin-2-one (WO 96/23788; 280 mg, 1 mmol), 3-hydroxyisoxazole (94 mg, 1.1 mmol), and triphenylphosphine (330 mg, 1.25 mmol) were suspended by stirring in dry tetrahydrofuran (10 ml) under nitrogen at ambient temperature. Diisopropylazodicarboxylate (308 mg, 1.5 mmol) was added dropwise over 10 minutes. The suspension dissolved, and stirring was continued at the same temperature for 2 hours. The mixture was evaporated to dryness, and the residue purified by chromatography on a 20 g silica Mega Bond Elut® columns, eluting with a gradient increasing in polarity from 50 to 100% EtOAc in isohexane. Relevant fractions were combined and evaporated to give the desired product (206 mg). MS (ESP): 345 (MH+) for C16H13FN4O4.

후처리

  1. dissolutionThe suspension dissolved
  2. customThe mixture was evaporated to dryness
  3. customthe residue purified by chromatography on a 20 g silica Mega Bond Elut® columns
  4. washeluting with
  5. temperaturea gradient increasing in polarity from 50 to 100% EtOAc in isohexane
  6. customevaporated

출처 및 근거

ORD 기록
ord-b3b6251e19af4ef2a1c434e00097a7ce
출처 데이터셋
uspto-grants-2003_09
특허 번호
US06617339B1

연결된 노트

불러오는 중…